Home › Companies › KRYSTAL BIOTECH INC. › 2024-2025
Compiled from SEC Form N-PX filings and KRYSTAL BIOTECH INC.’s Form 8-K, filed May 19, 2025 (Item 5.07 on EDGAR). Page generated November 1, 2026.
Meeting of May 16, 2025: 5 items on KRYSTAL BIOTECH INC.’s Form 8-K, filed May 19, 2025: 2 approved · 3 without a stated outcome.
None.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Explore KRYSTAL BIOTECH INC. in the interactive database Compare manager voting policies
These tallies are KRYSTAL BIOTECH INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 19, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Daniel S. Janney | 19,838,511 | -- | -- | 4,134,755 | 3,770,846 | 83% | Not verified | — |
| Elect Director: Dino A. Rossi | 23,336,879 | -- | -- | 636,387 | 3,770,846 | 97% | Not verified | — |
| Elect Director: E. Rand Sutherland, M.D. | 23,337,104 | -- | -- | 636,162 | 3,770,846 | 97% | Not verified | — |
| 2. Ratification of Appointment of Independent Registered Public Accounting Firm | 27,723,997 | 14,761 | 5,354 | -- | -- | 99.9% | Approved | — |
| 3. Non-Binding, Advisory Vote on Named Executive Officer Compensation | 22,543,683 | 1,423,437 | 6,146 | -- | 3,770,846 | 94% | Approved | — |
Source: KRYSTAL BIOTECH INC., Form 8-K, filed with the SEC on May 19, 2025 — read the filing on EDGAR.
Each item below shows how the 306 asset managers that disclosed a KRYSTAL BIOTECH INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 6 wordings of this item as funds reported it.
83% Majority: yes · of votes cast
Description as filed by funds: Election of Class II Directors: Daniel S. Janney
KRYSTAL BIOTECH INC.’s own tally for this item (“Elect Director: Daniel S. Janney”): 19,838,511 for, 4,134,755 withheld, per its Form 8-K filed May 19, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 83% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 101 asset managers below reported 11,801,640 for, 1,432,937 withheld, 153,424 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 3,666,746 | 0 | 0 | 0 | For |
| Vanguard | 2,766,174 | 0 | 5 | 1,062 | For |
| BlackRock | 2,322,314 | 0 | 0 | 0 | For |
| Capital Group | 887,104 | 0 | 0 | 0 | For |
| State Street | 617,834 | 0 | 0 | 18,079 | For |
| T. Rowe Price | 361,668 | 0 | 0 | 130,867 | Mixed |
| Dimensional | 0 | 0 | 0 | 392,584 | Withhold |
| Manager Directed Portfolios | 302,941 | 0 | 0 | 0 | For |
| Charles Schwab | 226,541 | 0 | 0 | 0 | For |
| TIAA | 190,300 | 0 | 0 | 0 | For |
| Invesco | 0 | 0 | 0 | 123,297 | Withhold |
| MUTUAL FUND SERIES TRUST | 95,781 | 0 | 0 | 1,588 | For |
| Lord Abbett | 0 | 0 | 0 | 86,545 | Withhold |
| Jackson National | 0 | 0 | 86,420 | 0 | Abstain |
| Equitable | 43,146 | 0 | 0 | 29,460 | Mixed |
| NEW ECONOMY FUND | 63,927 | 0 | 0 | 0 | For |
| Aberdeen | 0 | 0 | 0 | 57,033 | Withhold |
| Columbia Threadneedle | 0 | 0 | 0 | 53,792 | Withhold |
| Victory Capital | 0 | 0 | 0 | 53,301 | Withhold |
| OBERWEIS FUNDS | 0 | 0 | 0 | 46,800 | Withhold |
| John Hancock | 27,802 | 0 | 18,102 | 0 | Mixed |
| Voya | 0 | 0 | 0 | 43,785 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 42,274 | 0 | 0 | 0 | For |
| Lincoln Financial | 26,346 | 0 | 0 | 13,590 | Mixed |
| Nuveen | 36,953 | 0 | 0 | 0 | For |
Showing the 25 largest of 101 asset managers. See all 101 in the interactive database.
Combines 6 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Description as filed by funds: Election of Class II Directors: Dino A. Rossi
KRYSTAL BIOTECH INC.’s own tally for this item (“Elect Director: Dino A. Rossi”): 23,336,879 for, 636,387 withheld, per its Form 8-K filed May 19, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 101 asset managers below reported 12,921,619 for, 450,310 withheld, 16,072 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 3,666,746 | 0 | 0 | 0 | For |
| Vanguard | 2,767,240 | 0 | 1 | 0 | For |
| BlackRock | 2,322,314 | 0 | 0 | 0 | For |
| Capital Group | 887,104 | 0 | 0 | 0 | For |
| State Street | 635,913 | 0 | 0 | 0 | For |
| T. Rowe Price | 492,535 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 392,584 | Withhold |
| Manager Directed Portfolios | 302,941 | 0 | 0 | 0 | For |
| Charles Schwab | 226,541 | 0 | 0 | 0 | For |
| TIAA | 190,300 | 0 | 0 | 0 | For |
| Invesco | 123,297 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 97,369 | 0 | 0 | 0 | For |
| Lord Abbett | 86,545 | 0 | 0 | 0 | For |
| Jackson National | 80,305 | 0 | 6,115 | 0 | Mixed |
| Equitable | 43,146 | 0 | 0 | 29,460 | Mixed |
| NEW ECONOMY FUND | 63,927 | 0 | 0 | 0 | For |
| Aberdeen | 57,033 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 53,792 | 0 | 0 | 0 | For |
| Victory Capital | 53,301 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 46,800 | 0 | 0 | 0 | For |
| John Hancock | 36,612 | 0 | 9,292 | 0 | Mixed |
| Voya | 43,785 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 42,274 | 0 | 0 | 0 | For |
| Lincoln Financial | 37,400 | 0 | 0 | 2,536 | Mixed |
| Nuveen | 36,953 | 0 | 0 | 0 | For |
Showing the 25 largest of 101 asset managers. See all 101 in the interactive database.
Combines 6 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Description as filed by funds: Election of Class II Directors: E. Rand Sutherland
KRYSTAL BIOTECH INC.’s own tally for this item (“Elect Director: E. Rand Sutherland, M.D.”): 23,337,104 for, 636,162 withheld, per its Form 8-K filed May 19, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 101 asset managers below reported 12,939,819 for, 432,110 withheld, 16,072 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 3,666,746 | 0 | 0 | 0 | For |
| Vanguard | 2,767,240 | 0 | 1 | 0 | For |
| BlackRock | 2,322,314 | 0 | 0 | 0 | For |
| Capital Group | 887,104 | 0 | 0 | 0 | For |
| State Street | 635,913 | 0 | 0 | 0 | For |
| T. Rowe Price | 492,535 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 392,584 | Withhold |
| Manager Directed Portfolios | 302,941 | 0 | 0 | 0 | For |
| Charles Schwab | 226,541 | 0 | 0 | 0 | For |
| TIAA | 190,300 | 0 | 0 | 0 | For |
| Invesco | 123,297 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 97,369 | 0 | 0 | 0 | For |
| Lord Abbett | 86,545 | 0 | 0 | 0 | For |
| Jackson National | 80,305 | 0 | 6,115 | 0 | Mixed |
| Equitable | 43,146 | 0 | 0 | 29,460 | Mixed |
| NEW ECONOMY FUND | 63,927 | 0 | 0 | 0 | For |
| Aberdeen | 57,033 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 53,792 | 0 | 0 | 0 | For |
| Victory Capital | 53,301 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 46,800 | 0 | 0 | 0 | For |
| John Hancock | 36,612 | 0 | 9,292 | 0 | Mixed |
| Voya | 43,785 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 42,274 | 0 | 0 | 0 | For |
| Lincoln Financial | 37,400 | 0 | 0 | 2,536 | Mixed |
| Nuveen | 36,953 | 0 | 0 | 0 | For |
Showing the 25 largest of 101 asset managers. See all 101 in the interactive database.
Combines 11 wordings of this item as funds reported it.
94% Approved · of votes cast
Description as filed by funds: Approval of the compensation of the Company's named executive officers, on a non-binding, advisory basis.
KRYSTAL BIOTECH INC.’s own tally for this item (“3. Non-Binding, Advisory Vote on Named Executive Officer Compensation”): 22,543,683 for, 1,423,437 against — passed, per its Form 8-K filed May 19, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal Three: Non-Binding, Advisory Vote on Named Executive Officer Compensation The Company's stockholders approved, on an advisory (non-binding) basis, the compensation of the Company's named executive officers for the fiscal year ended December 31, 2024, as disclosed in the Company's proxy sta…”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 3,666,746 | 0 | 0 | 0 | For |
| Vanguard | 2,767,239 | 2 | 0 | 0 | For |
| BlackRock | 2,322,314 | 0 | 0 | 0 | For |
| Capital Group | 0 | 887,104 | 0 | 0 | Against |
| State Street | 620,376 | 15,537 | 0 | 0 | For |
| T. Rowe Price | 492,535 | 0 | 0 | 0 | For |
| Dimensional | 392,584 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 302,941 | 0 | 0 | 0 | For |
| Charles Schwab | 226,541 | 0 | 0 | 0 | For |
| TIAA | 190,300 | 0 | 0 | 0 | For |
| Invesco | 123,297 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 97,369 | 0 | 0 | 0 | For |
| Lord Abbett | 86,545 | 0 | 0 | 0 | For |
| Jackson National | 86,420 | 0 | 0 | 0 | For |
| Equitable | 72,606 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 0 | 63,927 | 0 | 0 | Against |
| Aberdeen | 57,033 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 0 | 53,792 | 0 | 0 | Against |
| Victory Capital | 53,301 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 46,800 | 0 | 0 | 0 | For |
| John Hancock | 45,904 | 0 | 0 | 0 | For |
| Voya | 43,785 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 42,274 | 0 | 0 | 0 | For |
| Lincoln Financial | 39,936 | 0 | 0 | 0 | For |
| Nuveen | 36,953 | 0 | 0 | 0 | For |
Fund voting reports, all 102 managers: 12,332,623 for, 1,042,579 against, 3,400 abstained. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 4,284,481 | 0 | 0 | 0 | For |
| Avoro Capital Advisors LLC | 2,201,928 | 0 | 0 | 0 | For |
| State Street | 1,104,506 | 15,616 | 0 | 0 | For |
| Capital Group | 0 | 954,468 | 0 | 0 | Against |
| Redmile Group, LLC | 737,675 | 0 | 0 | 0 | For |
| Frazier Life Sciences Management, L.P. | 688,460 | 0 | 0 | 0 | For |
| T. Rowe Price | 659,151 | 0 | 0 | 0 | For |
| BlackRock | 613,185 | 10,371 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 607,386 | 0 | 0 | 0 | For |
| Hood River Capital Management LLC | 487,191 | 0 | 0 | 0 | For |
| BRAIDWELL LP | 288,123 | 0 | 0 | 0 | For |
| Charles Schwab | 250,258 | 0 | 0 | 0 | For |
| Soleus Capital Management, L.P. | 235,396 | 0 | 0 | 0 | For |
| Nuveen | 231,205 | 0 | 0 | 0 | For |
| Woodline Partners LP | 218,043 | 0 | 0 | 0 | For |
| Invesco | 174,862 | 0 | 0 | 0 | For |
| Northern Trust | 159,277 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 132,571 | 0 | 0 | 0 | For |
| PRINCIPAL GLOBAL INVESTORS | 126,507 | 0 | 0 | 0 | For |
| LORD, ABBETT & CO. LLC | 99,350 | 0 | 0 | 0 | For |
| S Squared Technology, LLC | 99,215 | 0 | 0 | 0 | For |
| Victory Capital | 96,195 | 0 | 0 | 0 | For |
| TimesSquare Capital Management, LLC | 94,896 | 0 | 0 | 0 | For |
| JPMorgan | 92,437 | 0 | 0 | 0 | For |
| Vanguard | 90,571 | 0 | 0 | 0 | For |
Institutional-manager reports, all 233 managers: 15,048,584 for, 1,282,446 against, 18,200 withheld, 14 not voted. Showing the 25 largest; see all in the interactive database.
Combines 3 wordings of this item as funds reported it.
99.9% Approved · of votes cast
Description as filed by funds: To ratify the appointment of KPMG LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2025.
KRYSTAL BIOTECH INC.’s own tally for this item (“2. Ratification of Appointment of Independent Registered Public Accounting Firm”): 27,723,997 for, 14,761 against — passed, per its Form 8-K filed May 19, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal Two: Ratification of Appointment of Independent Registered Public Accounting Firm The Company's stockholders ratified the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 103 asset managers below reported 13,377,911 for, 11,054 against, 3,400 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 3,666,746 | 0 | 0 | 0 | For |
| Vanguard | 2,767,241 | 0 | 0 | 0 | For |
| BlackRock | 2,322,314 | 0 | 0 | 0 | For |
| Capital Group | 887,104 | 0 | 0 | 0 | For |
| State Street | 635,913 | 0 | 0 | 0 | For |
| T. Rowe Price | 492,535 | 0 | 0 | 0 | For |
| Dimensional | 392,584 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 302,941 | 0 | 0 | 0 | For |
| Charles Schwab | 226,541 | 0 | 0 | 0 | For |
| TIAA | 190,300 | 0 | 0 | 0 | For |
| Invesco | 123,297 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 97,369 | 0 | 0 | 0 | For |
| Lord Abbett | 86,545 | 0 | 0 | 0 | For |
| Jackson National | 86,420 | 0 | 0 | 0 | For |
| Equitable | 72,606 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 63,927 | 0 | 0 | 0 | For |
| Aberdeen | 57,033 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 53,792 | 0 | 0 | 0 | For |
| Victory Capital | 53,301 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 46,800 | 0 | 0 | 0 | For |
| John Hancock | 45,904 | 0 | 0 | 0 | For |
| Voya | 43,785 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 42,274 | 0 | 0 | 0 | For |
| Lincoln Financial | 39,936 | 0 | 0 | 0 | For |
| Nuveen | 36,953 | 0 | 0 | 0 | For |
Showing the 25 largest of 103 asset managers. See all 103 in the interactive database.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 28,899,000 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 12.69% |
| 2 | Vanguard | 9.58% |
| 3 | BlackRock | 8.04% |
| 4 | Capital Group | 3.07% |
| 5 | State Street | 2.20% |
| 6 | T. Rowe Price | 1.70% |
| 7 | Dimensional | 1.36% |
| 8 | Manager Directed Portfolios | 1.05% |
| 9 | Charles Schwab | 0.78% |
| 10 | TIAA | 0.66% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 14.83% |
| 2 | Avoro Capital Advisors LLC | 7.62% |
| 3 | State Street | 3.88% |
| 4 | Capital Group | 3.30% |
| 5 | Redmile Group, LLC | 2.55% |
| 6 | Frazier Life Sciences Management, L.P. | 2.38% |
| 7 | T. Rowe Price | 2.28% |
| 8 | BlackRock | 2.16% |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 2.10% |
| 10 | Hood River Capital Management LLC | 1.69% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| FMR (Fidelity) | 14.95% | 13F |
| FMR LLC | 14.85% | DEF14A |
| BlackRock | 13.64% | 13F |
| Krish S. Krishnan | 11.72% | 13G |
| Vanguard Group | 9.78% | 13F |
| Avoro Capital Advisors LLC | 8.88% | DEF14A |
| Suma M. Krishnan | 5.88% | DEF14A |
| STATE STREET CORPORATION | 4.43% | 13G |
| Dimensional Fund Advisors | 1.85% | 13F |
| T. Rowe Price | 1.42% | 13F |
Percentages above are of 28,899,000 shares outstanding, as reported by KRYSTAL BIOTECH INC. on its Form 10-Q dated March 31, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from KRYSTAL BIOTECH INC.’s 10-Q dated March 31, 2025. This page is a static snapshot rebuilt weekly on November 1, 2026; a live search always shows the current data.
At KRYSTAL BIOTECH INC.'s shareholder meeting held May 16, 2025, in the 2024-2025 proxy season, 306 asset managers reported how they voted on 5 ballot items in their SEC Form N-PX filings, covering 2,145 separate fund positions. On the most widely held item on that ballot — Approval of the compensation of the Company's named executive officers, on a non-binding… — KRYSTAL BIOTECH INC.'s filing reports the proposal as approved, with 94% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: KRYSTAL BIOTECH INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 19, 2025.
KRYSTAL BIOTECH INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.
Download data (CSV): ballot items · votes by manager · column guide.